Literature DB >> 25099932

Genetic convergence of Parkinson's disease and lysosomal storage disorders.

Hao Deng1, Xiaofei Xiu, Joseph Jankovic.   

Abstract

Parkinson's disease is a common progressive neurodegenerative disorder characterized by predominant degeneration of the dopaminergic neurons in the substantia nigra pars compacta and the presence of intracellular inclusions enriched in α-synuclein, resulting in a variety motor and nonmotor symptoms. Lysosomal storage disorders are a group of disorders including Gaucher disease, Niemann-Pick disease, and neuronal ceroid lipofuscinoses caused by the defective activity of lysosomal and nonlysosomal proteins. In addition to an overlap in some clinical features between lysosomal storage disorders and Parkinson's disease, the two disorders may be also linked pathogenically. There is growing support for the notion that mutations in genes causing lysosomal storage disorders including the glucocerebrosidase gene, the sphingomyelin phosphodiesterase 1 gene, and the NPC1 gene may increase risk for developing Parkinson's disease. In this review, we discuss the recent advances in the genetic convergence of Parkinson's disease and lysosomal storage disorders, shedding new light on the understanding of shared pathogenic pathways.

Entities:  

Mesh:

Year:  2014        PMID: 25099932     DOI: 10.1007/s12035-014-8832-4

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  162 in total

1.  Glucocerebrosidase mutations are also found in subjects with early-onset parkinsonism from Venezuela.

Authors:  Michael J Eblan; Joann Nguyen; Shira G Ziegler; Alicia Lwin; Melissa Hanson; Marisol Gallardo; Roberto Weiser; Marisel De Lucca; Andrew Singleton; Ellen Sidransky
Journal:  Mov Disord       Date:  2006-02       Impact factor: 10.338

2.  Differential phenotype in Parkinson's disease patients with severe versus mild GBA mutations.

Authors:  Z Gan-Or; N Giladi; A Orr-Urtreger
Journal:  Brain       Date:  2009-06-05       Impact factor: 13.501

3.  Mutations in the glucocerebrosidase gene confer a risk for Parkinson disease in North Africa.

Authors:  S Lesage; C Condroyer; N Hecham; M Anheim; S Belarbi; E Lohman; F Viallet; P Pollak; M Abada; A Dürr; M Tazir; A Brice
Journal:  Neurology       Date:  2011-01-18       Impact factor: 9.910

Review 4.  Glucocerebrosidase, a new player changing the old rules in Lewy body diseases.

Authors:  Na-Young Yang; Yu-Na Lee; He-Jin Lee; Yoon Suk Kim; Seung-Jae Lee
Journal:  Biol Chem       Date:  2013-07       Impact factor: 3.915

5.  Altered gene expression in cells from patients with lysosomal storage disorders suggests impairment of the ubiquitin pathway.

Authors:  P Bifsha; K Landry; L Ashmarina; S Durand; V Seyrantepe; S Trudel; C Quiniou; S Chemtob; Y Xu; R A Gravel; R Sladek; A V Pshezhetsky
Journal:  Cell Death Differ       Date:  2006-08-04       Impact factor: 15.828

6.  Occurrence of Parkinson's syndrome in type I Gaucher disease.

Authors:  O Neudorfer; N Giladi; D Elstein; A Abrahamov; T Turezkite; E Aghai; A Reches; B Bembi; A Zimran
Journal:  QJM       Date:  1996-09

Review 7.  Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).

Authors:  Kathleen S Hruska; Mary E LaMarca; C Ronald Scott; Ellen Sidransky
Journal:  Hum Mutat       Date:  2008-05       Impact factor: 4.878

Review 8.  Genetic causes of Parkinson's disease and their links to autophagy regulation.

Authors:  Ping-Yue Pan; Zhenyu Yue
Journal:  Parkinsonism Relat Disord       Date:  2014-01       Impact factor: 4.891

9.  Functional implications of novel human acid sphingomyelinase splice variants.

Authors:  Cosima Rhein; Philipp Tripal; Angela Seebahn; Alice Konrad; Marcel Kramer; Christine Nagel; Jonas Kemper; Jens Bode; Christiane Mühle; Erich Gulbins; Martin Reichel; Cord-Michael Becker; Johannes Kornhuber
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

10.  Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis.

Authors:  Jose Bras; Alain Verloes; Susanne A Schneider; Sara E Mole; Rita J Guerreiro
Journal:  Hum Mol Genet       Date:  2012-03-02       Impact factor: 6.150

View more
  11 in total

1.  Glial α-synuclein promotes neurodegeneration characterized by a distinct transcriptional program in vivo.

Authors:  Abby L Olsen; Mel B Feany
Journal:  Glia       Date:  2019-07-03       Impact factor: 7.452

Review 2.  Astrocytes and lysosomal storage diseases.

Authors:  K V Rama Rao; T Kielian
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

3.  Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease.

Authors:  Laurie A Robak; Iris E Jansen; Jeroen van Rooij; André G Uitterlinden; Robert Kraaij; Joseph Jankovic; Peter Heutink; Joshua M Shulman
Journal:  Brain       Date:  2017-12-01       Impact factor: 13.501

4.  β2-adrenergic Agonists Rescue Lysosome Acidification and Function in PSEN1 Deficiency by Reversing Defective ER-to-lysosome Delivery of ClC-7.

Authors:  Ju-Hyun Lee; Devin M Wolfe; Sandipkumar Darji; Mary Kate McBrayer; Daniel J Colacurcio; Asok Kumar; Philip Stavrides; Panaiyur S Mohan; Ralph A Nixon
Journal:  J Mol Biol       Date:  2020-02-24       Impact factor: 5.469

Review 5.  Disorders of lysosomal acidification-The emerging role of v-ATPase in aging and neurodegenerative disease.

Authors:  Daniel J Colacurcio; Ralph A Nixon
Journal:  Ageing Res Rev       Date:  2016-05-16       Impact factor: 10.895

6.  Anomalies in Dopamine Transporter Expression and Primary Cilium Distribution in the Dorsal Striatum of a Mouse Model of Niemann-Pick C1 Disease.

Authors:  Micaela Lucarelli; Chiara Di Pietro; Gina La Sala; Maria Teresa Fiorenza; Daniela Marazziti; Sonia Canterini
Journal:  Front Cell Neurosci       Date:  2019-05-24       Impact factor: 5.505

Review 7.  Recent Insights into NCL Protein Function Using the Model Organism Dictyostelium discoideum.

Authors:  Meagan D McLaren; Sabateeshan Mathavarajah; Robert J Huber
Journal:  Cells       Date:  2019-02-02       Impact factor: 7.666

Review 8.  Molecular networking in the neuronal ceroid lipofuscinoses: insights from mammalian models and the social amoeba Dictyostelium discoideum.

Authors:  Robert J Huber
Journal:  J Biomed Sci       Date:  2020-05-20       Impact factor: 8.410

Review 9.  Using the social amoeba Dictyostelium to study the functions of proteins linked to neuronal ceroid lipofuscinosis.

Authors:  Robert J Huber
Journal:  J Biomed Sci       Date:  2016-11-24       Impact factor: 12.771

10.  Brain RNA-Seq Profiling of the Mucopolysaccharidosis Type II Mouse Model.

Authors:  Marika Salvalaio; Francesca D'Avanzo; Laura Rigon; Alessandra Zanetti; Michela D'Angelo; Giorgio Valle; Maurizio Scarpa; Rosella Tomanin
Journal:  Int J Mol Sci       Date:  2017-05-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.